Aims: Identifying age‐dependent basal rates in type 1 diabetic children treated with
continuous subcutaneous insulin infusion (CSII). Methods: CSII‐treated children with type 1 …

Objective The aim of our study was to explore a possible relationship between proportion of
basal insulin dose (% BD/T) and glycaemic control in children with type I diabetes on …

The aim of this study was to evaluate clinical and metabolic data in a cohort of Type 1
diabetes (T1DM) children before and after 2 yr of continuous sc insulin infusion (CSII). Forty …

Bachran R, Beyer P, Klinkert C, Heidtmann B, Rosenbauer J, Holl RW; for the
German/Austrian DPV Initiative, the German Pediatric CSII Working Group and the BMBF …

Objective: This study analyzed the changes in insulin requirement in the transition from
multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII) and the …

OBJECTIVE: To examine the effect of continuous subcutaneous insulin infusion (CSII)
therapy on parameters affecting long-term outcome in type 1 diabetes. STUDY DESIGN …

Aim: To evaluate the safety and efficacy of continuous subcutaneous insulin infusion (CSII)
in children under 7 years of age. Methods: One hundred and ten children, aged 0.9–7 years …

AIM: This study was aimed at investigation of daily glycemic variations in children and
adolescents with type 1 diabetes mellitus (T1DM) on continuous subcutaneous insulin …

Aim To evaluate the efficacy and safety of continuous subcutaneous insulin infusion (CSII),
and its impact on glycaemic control, insulin doses and auxological parameters in children …

Objective: This study intends to analyse the basal insulin dosage for pediatric patients (0-18
years) with type 1 diabetes on insulin-pump therapy (CSII). Research design and methods …